INTERNATIONAL PATENT: BIONTECH SE, TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH FILES APPLICATION FOR "AGENTS AND METHODS FOR TARGETED DELIVERY OF CYTOKINES TO IMMUNE CELLS"

GENEVA, Feb. 3 -- BIONTECH SE (An der Goldgrube 1255131 Mainz), TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH (Freiligrathstrasse 1255131 Mainz) filed a patent application (PCT/EP2024/070487) for "AGENTS AND METHODS FOR TARGETED DELIVERY OF CYTOKINES TO IMMUNE CELLS" on Jul 19, 2024. With publication no. WO/2025/021668, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GANGLUFF, Meike (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), SAHN, Ugur (c/o Bio...